CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Emerging interventional treatments in the management of pediatric brain tumors.
Emerging interventional treatments in the management of pediatric brain tumors.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
近年来,对儿童脑肿瘤生物学分子层面的理解取得的进展,显著促进了旨在改善患病儿童临床结局的创新治疗策略的开发。这些科学突破有助于识别儿童脑肿瘤发生过程中不可或缺的特定分子靶点和信号通路,从而使设计能够破坏这些致病过程的靶向治疗成为可能。此外,免疫治疗和精准医学方法的引入开辟了新的治疗途径,为更有效且毒性更低的治疗模式提供了可能。随着该领域研究的持续推进,这些前沿治疗干预措施有望提高儿童患者的生存率并改善其生活质量。本综述阐述了儿童脑肿瘤管理中新兴的介入治疗,并探讨了该领域持续存在的挑战。
Recent advancements in the molecular understanding of pediatric brain tumor biology have significantly contributed to the development of innovative therapeutic strategies aimed at improving clinical outcomes for affected children. These scientific breakthroughs have facilitated the identification of specific molecular targets and signaling pathways integral to the oncogenesis of pediatric brain tumors, thereby enabling the design of targeted therapies that disrupt these pathogenic processes.
Furthermore, the incorporation of immunotherapy and precision medicine approaches has unveiled novel therapeutic avenues, offering the potential for more efficacious and less toxic treatment modalities. As research in this domain continues to progress, these cutting-edge therapeutic interventions are anticipated to enhance survival rates and improve the quality of life for pediatric patients. This review delineates emerging interventional treatments in pediatric brain tumor management and examines the persistent challenges within the field.
MEMBER ACCOUNT
登录成功会直接打开下一页。